Wael Aljaroudi Selected Research

Wael Aljaroudi Research Topics

3	Myocardial Infarction 01/2022 - 01/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 05/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Stroke (Strokes) 01/2022
1	Acute Coronary Syndrome 01/2022
1	Stable Angina 01/2022
1	Mitral Valve Insufficiency (Mitral Regurgitation) 05/2018
1	Left Ventricular Dysfunction 04/2014
1	Chronic Renal Insufficiency 04/2013
1	Tachycardia (Tachyarrhythmias) 04/2013
1	Myocardial Ischemia (Ischemic Heart Diseases) 05/2011
1	End Stage Liver Disease 02/2011
1	Cardiomyopathies (Cardiomyopathy) 06/2010
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2010
1	Infarction (Infarctions) 01/2010
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2010
1	Pulmonary Hypertension 07/2008
1	Pericardial Effusion 07/2008

2	regadenoson FDA Link 02/2011 - 01/2010
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Ranolazine FDA Link 05/2011
1	Vasodilator Agents (Vasodilators)IBA 05/2011
1	Biomarkers (Surrogate Marker)IBA 01/2010
1	Troponin IIBA 01/2010

4	Therapeutics 05/2018 - 06/2010
1	Stents 01/2022
1	Percutaneous Coronary Intervention 01/2022
1	Secondary Prevention 04/2013
1	Defibrillators (Defibrillator) 04/2013
1	Pericardiectomy 07/2008